Heghine Khachatryan: World Federation of Hemophilia Is Far More Than An Organization
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from WFH on LinkedIn:
”WFH’s work consistently reinforces a critical truth:
bleeding disorders are not only medical conditions — they are issues of health equity, gender equity, and human rights.
-For clinicians, WFH represents knowledge, standards, and professional growth
-For patients, it provides voice, visibility, and dignity
– For health systems, it offers a sustainable model for organizing rare disease care.
World Federation of Hemophilia (WFH) is far more than an organization — it is a global movement that has fundamentally transformed the lives of people living with hemophilia and other inherited bleeding disorders worldwide.
As 2025 comes to a close, WFH’s impact is particularly evident in several key areas:
• increasing global awareness of hemophilia and bleeding disorders,
• addressing the long-standing underdiagnosis of bleeding disorders in women and girls,
• strengthening continuous medical education for healthcare professionals,
• advancing laboratory standards, clinical guidelines, and evidence-based care, and
• expanding equitable access to safe and effective treatment.
With gratitude for WFH’s global leadership, collaboration, and unwavering commitment to patient-centered care.”
Qutoing World Federation of Hemophilia‘s post:
”As 2025 comes to a close, the World Federation of Hemophilia is celebrating a year of meaningful progress for people with hemophilia and Bleeding Disorders around the world.
Thanks to our global community, partners, and volunteers, this year saw important milestones, from expanding diagnosis and care to strengthening humanitarian aid and advancing treatment standards.
Read more.
Wishing our community a bright start to 2026, we look forward to connecting with you in Malaysia for the WFH 2026 World Congress!”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment
-
Oct 19, 2026, 16:04Hussnain Javaid: New EHA Guidelines for HbSC Disease Management